MedicineBiology

Zi-Xin Tian, Jun Zhang, Zi-Xuan Wang, Xi Song, Yi-Tao Zhou, Ying Hu

2026.1.30Balkan Medical Journal

DOI: 10.4274/balkanmedj.galenos.2026.2025-11-226

tlooto Summary

Two individually benign variants can combine to form a novel pathogenic haplotype and this mechanism may be under-recognized in routine variant interpretation pipelines, underscore the importance of evaluating the combined effects of linked benign variants to ensure accurate genetic counseling.

Abstract

Background Aberrations in cadherin-related 23 (CDH23) account for a significant proportion of familial autosomal recessive non-syndromic hearing loss (DFNB12), a common subtype of hereditary hearing loss worldwide.

Aims This study aimed to elucidate the molecular basis and pathogenic mechanism of DFNB12 in an affected girl from a nine-member pedigree.

Study Design Family-based genetic study with pedigree analysis.

Methods Clinical whole-exome sequencing combined with pedigree analysis was used to identify disease-causing mutations. The potential functional consequences of these mutations were investigated using structural bioinformatic approaches, including homology modeling, molecular dynamics simulations, and other relevant tools.

Results The proband carried compound heterozygous variants: a known pathogenic maternal variant (c.6049G > A) and a paternal haplotype comprising two linked variants (c.3262G > A and c.6911G > A), each individually classified as benign. Pedigree segregation analysis demonstrated that the paternal haplotype acts as a single pathogenic allele.

Conclusion Two individually benign variants can combine to form a novel pathogenic haplotype (c.3262A-c.6911A). This mechanism may be under-recognized in routine variant interpretation pipelines. Our findings underscore the importance of evaluating the combined effects of linked benign variants to ensure accurate genetic counseling.

Citation format

TIAN, Zi-Xin, et al. A novel pathogenic haplotype in CDH23 causing DFNB12: The combined effect of two individually benign variants. Balkan Medical Journal, 2026, 43(4): 206–211.